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Fig. 1. Cytopathological features of adrenal carcinoma. (a) Malignant cells arranged in follicular or trabecular appearance along fibrou s and 
vascular structures (May- Grünwald-Giemsa stain, x 100). (b) Multinucleated cells with giant nuciei, prominent nucleoli and abundant, 
vacuolated, clear and badly delimited cytoplasm (May-Grünwald-Giemsa stain, x 400), 
HIV-related ocular microangiopathic syndrome and neuropsychological functioning 
Wilkie et al. [1] recently reported that cognitive alter-
ations occur in HN-1-infected individuals before the 
manifestation of AIDS, and appear to be indepen-
dent of the clinical status and degree of immuno-
suppression as measured by CD4 ceH count and im-
munoglobulin A (IgA) level. The association between 
HN-1 serostatus and cognitive impairment has not 
been completely explained by known potentially con-
founding factors, such as age, education and psycho-
pathological status [1] . 
The fact that not all HN-infected patients develop cog-
nitive impairment or progress to a dementia ~yndrome 
suggests that factors other than HN-1 are respon-
sible for this condition. Dunbar et al. [2] showed 
that neuropsychological changes are not exclusively 
associated with progression from AIDS-related com-
plex (ARe) to AIDS. The aetiology of cognitive symp-
toms may be multifactorial; pathological findings in 
computed cranial tomography or magnetic resonance 
imaging do not necessarily relate to neurocognitive de-
cline [3], psychogenic versus somatogenic reasons are 
to differentiate. 
In our study of 237 seropositive subjects we found 
that HN-1-seropositives showed reduced cognitive 
functioning compared with HN-negative controls, 
and detected significant correlations between psycho-
pathological impairment and neuropsychological func-
tioning [4]. To look for other influences on or pos-
sible explanations for a decrease in the memory func-
tions of HN-1-infected patients, a subgroup of 37 
sero positive subjects underwent ophthalmological and 
neuropsychological examination. We examined these 
patients to evaluate a possible association between 
HN-l -related ocular microangiopathic syndrome and 
cognitive functioning [5]. Ocular microangiopathic 
syndrome is common in patients with AIDS or at an 
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advanced stage of HN infection [6]. Symptoms of this 
microvascular syndrome can inelude retinal cotton-
wool spots, haemorrhages and Roth's spots [7]. 
There was a strong carrelation between HN-
related ocular microangiopathic syndrome, measured 
by counting the number of cotton-wool spots, and 
a decrease in cognitive functioning, determined by 
neuropsychological examination ineluding five stan-
dardized tests (Auditory Verbal Learning Test, Benton 
Test, Vocabulary, Stroop Colour Ward Test, Trail-
Making Test part B), in AIDS patients. The mul-
tiple correlation between the number of cotton-
wool spots and the five neuropsychological tests 
was r = 0.70 (p < 0.001). Ocular microangiopathic 
syndrome was also strongly associated with cere-
bral blood flow as measured by hexamethyl-propy-
leneamine oxime single-photon emission computed 
tomography (HMPAO-SPECT) of the brain [8]. 
These correlations between ocular microangiopathic 
syndrome, HMPAO-SPECT and cognitive performance 
do not prove a causal relationship, but indicate that 
there may be a elose association between cerebral 
blood flow and functional cerebral impairmeot. HN-
related microangiopathic syndrome may thus be in-
volved in the aetiology of cognitive alterations in HN-
infected individuals. 
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Decay of HIV-1 infectivity in whole blood, plasma and peripheral blood mononuclear cells 
Accurate quantitation of the level of HN-1 in vivo is 
important in understanding AIDS pathogenesis and vi-
ral transmission, as weil as in monitoring the efficacy of 
antiviral agents given to patients. We have previously 
defined the infectious levels of HN-1 in plasma and 
peripheral blood mononuelear cells (PEMe) from in-
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fected subjects [1]. We have also determined the in-
fectious titers in sequential blood sampies from pa-
tients with primary HN-1 infection [2]. These studies 
were performed in real time (i.e., immediately after any 
transport and processing delays) with freshly obtained 
blood sampies, and it is unclear whether the time de-
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Fig. 1. Decay of HIV-1 infectivity for whole blood (al, plasma (bl and peripheral blood mononuclear cells (PBMC); (cl from five patients 
with AIDS. 0, patient 1; e, patient 2, 0, patient 3; _ , patient 4; 6., patient S. TClD, tissue culture infective dose. 
